Evaluation of the Impact of Codon Optimization and N-Linked Glycosylation on Functional Immunogenicity of Pfs25 DNA Vaccines Delivered by In Vivo Electroporation in Preclinical Studies in Mice

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical and Vaccine Immunology

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/CVI.00185-15PMID 26135972PMCID PMC4550670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of malaria transmission-blocking vaccines: from concept to product.

  2015influential reference
• Detailed functional characterization of glycosylated and nonglycosylated variants of malaria vaccine candidate PfAMA1 produced in Nicotiana benthamiana and analysis of growth inhibitory responses in rabbits.

  2015cited by this paper
• Potent Malaria Transmission-Blocking Antibody Responses Elicited by Plasmodium falciparum Pfs25 Expressed in Escherichia coli after Successful Protein Refolding

  2014cited by this paper
• NIAID meeting report: improving malaria vaccine strategies through the application of immunological principles.

  2014cited by this paper
• A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine

  2014cited by this paper
• Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons.

  2013cited by this paper
• DNA based vaccines offer improved vaccination supply for the developing world

  2013cited by this paper
• Production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expressing bacterial PNGase F.

  2012cited by this paper
• A Research Agenda to Underpin Malaria Eradication

  2011cited by this paper
• Mutation of putative N-Linked Glycosylation Sites in Japanese encephalitis Virus Premembrane and Envelope proteins enhances humoral immunity in BALB/C mice after DNA vaccination

  2011cited by this paper
• Electroporation delivery of DNA vaccines: prospects for success.

  2011cited by this paper
• Electroporation for DNA immunization: clinical application

  2010cited by this paper
• Overlooked post-translational modifications of proteins in Plasmodium falciparum: N- and O-glycosylation -- a review.

  2010cited by this paper
• Production of recombinant proteins from protozoan parasites.

  2010cited by this paper
• Suggestive Evidence for Darwinian Selection against Asparagine-Linked Glycans of Plasmodium falciparum and Toxoplasma gondii

  2009cited by this paper
• Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.

  2008cited by this paper
• Murine Model for Assessment of Plasmodium falciparum Transmission-Blocking Vaccine Using Transgenic Plasmodium berghei Parasites Expressing the Target Antigen Pfs25

  2008cited by this paper
• Virus glycosylation: role in virulence and immune interactions

  2007cited by this paper
• Enhancement of immune responses to an HBV DNA vaccine by electroporation.

  2006cited by this paper
• Posttranslational Modification of Recombinant Plasmodium falciparum Apical Membrane Antigen 1: Impact on Functional Immune Responses to a Malaria Vaccine Candidate

  2005cited by this paper
• Induction of Plasmodium falciparum Transmission-Blocking Antibodies in Nonhuman Primates by a Combination of DNA and Protein Immunizations

  2004cited by this paper
• DNA vaccines: designing strategies against parasitic infections

  2004cited by this paper
• In vivo electroporationによる血管壁への遺伝子導入法の開発

  2004cited by this paper
• Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy.

  2004cited by this paper
• Transmission-blocking vaccines.

  2002cited by this paper
• The role of glycosylation in protein antigenic properties

  2002cited by this paper
• A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum

  2001cited by this paper
• Transmission blocking malaria vaccines.

  2001cited by this paper
• Immunization of Mice with DNA-Based Pfs25 Elicits Potent Malaria Transmission-Blocking Antibodies

  1999cited by this paper
• A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

  1988cited by this paper
• Biosynthesis of two stage-specific membrane proteins during transformation of Plasmodium gallinaceum zygotes into ookinetes.

  1985cited by this paper
• Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum

  1983cited by this paper
• The production of mature gametocytes of Plasmodium falciparum in continuous cultures of different isolates infective to mosquitoes.

  1982cited by this paper
• THE WORLD HEALTH ORGANIZATION

  1954cited by this paper

• Distinct immunogenicity outcomes of DNA vaccines encoding malaria transmission-blocking vaccine target antigens Pfs230D1M and Pvs230D1.

  2025cites this paper
• Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax.

  2024cites this paper
• Immune mechanisms targeting malaria transmission: opportunities for vaccine development

  2024cites this paper
• A novel ex vivo assay to evaluate functional effectiveness of Plasmodium vivax transmission blocking vaccine using Pvs25 transgenic P. berghei.

  2024cites this paper
• Malaria Vaccines: From the Past towards the mRNA Vaccine Era

  2023cites this paper
• The use of electroporation to deliver DNA-based vaccines

  2023cites this paper
• Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission

  2022cites this paper
• mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum

  2022cites this paper
• Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS

  2022cites this paper
• Design and assessment of TRAP-CSP fusion antigens as effective malaria vaccines

  2019cites this paper
• Adjuvant and Antigen Systems for Malaria Transmission‐Blocking Vaccines

  2018cites this paper
• Viral Modulation of Host Translation and Implications for Vaccine Development

  2018cites this paper
• Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques.

  2017cites this paper
• Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation.

  2017influential citation
• Impact of the Charge Ratio on the In Vivo Immunogenicity of Lipoplexes

  2017cites this paper
• Immunogenicity and immunizing protection effect of GAMA gene DNA vaccine on Plasmodium berghei.

  2016cites this paper
• Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates

  2016cites this paper